DE60202131D1 - Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen - Google Patents

Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen

Info

Publication number
DE60202131D1
DE60202131D1 DE60202131T DE60202131T DE60202131D1 DE 60202131 D1 DE60202131 D1 DE 60202131D1 DE 60202131 T DE60202131 T DE 60202131T DE 60202131 T DE60202131 T DE 60202131T DE 60202131 D1 DE60202131 D1 DE 60202131D1
Authority
DE
Germany
Prior art keywords
naphthostyril
cyclin
inhibitors
derivatives
dependent kinases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202131T
Other languages
English (en)
Other versions
DE60202131T2 (de
Inventor
Yi Chen
Apostolos Dermatakis
Martin Konzelmann
Jin-Jun Liu
Kin-Chun Luk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60202131D1 publication Critical patent/DE60202131D1/de
Publication of DE60202131T2 publication Critical patent/DE60202131T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60202131T 2001-01-23 2002-01-16 Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen Expired - Lifetime DE60202131T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26365801P 2001-01-23 2001-01-23
US263658P 2001-01-23
PCT/EP2002/000366 WO2002059109A2 (en) 2001-01-23 2002-01-16 Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases

Publications (2)

Publication Number Publication Date
DE60202131D1 true DE60202131D1 (de) 2005-01-05
DE60202131T2 DE60202131T2 (de) 2005-12-01

Family

ID=23002712

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202131T Expired - Lifetime DE60202131T2 (de) 2001-01-23 2002-01-16 Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen

Country Status (17)

Country Link
US (2) US6504034B2 (de)
EP (1) EP1358180B1 (de)
JP (1) JP4091434B2 (de)
KR (1) KR100563429B1 (de)
CN (1) CN1231479C (de)
AR (1) AR035738A1 (de)
AT (1) ATE283852T1 (de)
AU (1) AU2002240905B2 (de)
BR (1) BR0206621A (de)
CA (1) CA2434381C (de)
DE (1) DE60202131T2 (de)
ES (1) ES2232736T3 (de)
MX (1) MXPA03006423A (de)
PE (1) PE20020916A1 (de)
UY (1) UY27132A1 (de)
WO (1) WO2002059109A2 (de)
ZA (1) ZA200305383B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010013920A (es) * 2008-06-26 2011-02-21 Amgen Inc Alcoholes alquinilicos como inhibidores de cinasas.
CN109665987B (zh) * 2018-12-28 2022-02-18 河南大学 萘内酰亚胺-多胺缀合物及其制备方法和用途
WO2020210630A1 (en) * 2019-04-12 2020-10-15 C4 Therapeutics, Inc. Tricyclic degraders of ikaros and aiolos
JP2023545508A (ja) * 2020-10-14 2023-10-30 シーフォー セラピューティクス， インコーポレイテッド Ｉｋｚｆ２又はｉｋｚｆ４を分解する三環式リガンド
WO2023154417A1 (en) * 2022-02-09 2023-08-17 C4 Therapeutics, Inc. Morphic forms of cft7455 and methods of manufacture thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081131A (en) * 1986-01-13 1992-01-14 American Cyanamid Company Omega-((hetero)alkyl)benz(cd)-indol-2-amines
US5206261A (en) 1989-07-25 1993-04-27 Taiho Pharmaceutical Company, Limited Oxindole derivative
WO1992007830A2 (en) 1990-10-29 1992-05-14 Pfizer Inc. Oxindole peptide antagonists
FR2694004B1 (fr) 1992-07-21 1994-08-26 Adir Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
GB9313638D0 (en) 1993-07-01 1993-08-18 Erba Carlo Spa Arylidene and heteroarylidene oxindole derivatives and process for their preparation
GB9423997D0 (en) 1994-11-28 1995-01-11 Erba Carlo Spa Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
GB9501567D0 (en) 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9507298D0 (en) 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5880141A (en) 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
DE29513441U1 (de) 1995-08-22 1995-10-19 Engelhardt Rolf Aschenbecher zum Mitführen
AU4155697A (en) 1996-08-23 1998-03-06 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5750556A (en) * 1996-10-30 1998-05-12 American Home Products Corporation 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano- 2,3-E!indol-8-ones and derivatives
ATE292623T1 (de) 1997-05-07 2005-04-15 Sugen Inc 2-indolinonderivate als modulatoren der proteinkinase-ativität
WO2000035908A1 (en) 1998-12-17 2000-06-22 F. Hoffmann-La Roche Ag 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2

Also Published As

Publication number Publication date
BR0206621A (pt) 2004-02-25
AU2002240905B2 (en) 2007-03-01
JP4091434B2 (ja) 2008-05-28
CA2434381A1 (en) 2002-08-01
US20020147343A1 (en) 2002-10-10
WO2002059109A3 (en) 2002-09-19
JP2004517150A (ja) 2004-06-10
ES2232736T3 (es) 2005-06-01
PE20020916A1 (es) 2002-10-21
DE60202131T2 (de) 2005-12-01
WO2002059109A2 (en) 2002-08-01
ATE283852T1 (de) 2004-12-15
CN1231479C (zh) 2005-12-14
EP1358180A2 (de) 2003-11-05
KR100563429B1 (ko) 2006-03-22
EP1358180B1 (de) 2004-12-01
US6504034B2 (en) 2003-01-07
US6531598B1 (en) 2003-03-11
KR20030069223A (ko) 2003-08-25
CA2434381C (en) 2009-11-24
CN1487931A (zh) 2004-04-07
MXPA03006423A (es) 2003-10-15
ZA200305383B (en) 2004-10-11
AR035738A1 (es) 2004-07-07
UY27132A1 (es) 2002-07-31

Similar Documents

Publication Publication Date Title
DE60325761D1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
DE60221233D1 (de) Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren
ATE315554T1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
ATE332896T1 (de) 4-aminothiazol derivate, deren herstellung und deren verwendung als inhibitoren cyclin- abhängiger kinasen
DE60030574D1 (de) Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
ATE394102T1 (de) Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60221886D1 (de) 3-cyanochinoline als inhibitoren von egf-r- und her2-kinasen
CY2011016I2 (el) Λακταμουχες ενωσεις και παραγωγα αυτων ως αναστολεις του παραγοντα χα
DE60321808D1 (de) Flavon derivate als inhibitoren von cyclin-abhängigen kinasen
DE60121595D1 (de) Mannich base prodrugs von 3-(pyrrol-2-ylmethylidene)-2-indolinon derivate und deren verwendung als protein kinase inhibitoren
DE60113719D1 (de) Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
DE60234167D1 (de) Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren
ATE299881T1 (de) 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren
DE60332023D1 (de) Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
DE60208351D1 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
DE60020100D1 (de) Dimerverbindungen und als inhibitoren der neuramidinase
DE60324805D1 (de) Inhibitoren von tyrosinkinasen
ATE521598T1 (de) 5-phenylthiazol-derivate und ihre verwendung als pi3 kinase inhibitoren
DE60223841D1 (de) Medizinische verwendung von gsk3-hemmenden oxindolderivaten
DE50311397D1 (de) Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
EE200300491A (et) 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
ATE308323T1 (de) Diaminothiazole und ihre anwendung als cdk4 inhibitoren
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition